PSA screening: the bottom line

Elhilali, Mostafa M.
March 2000
CMAJ: Canadian Medical Association Journal;3/21/2000, Vol. 162 Issue 6, p791
Academic Journal
Discusses the effectiveness of the prostate-specific antigen (PSA) test for prostate cancer. Belief that early diagnosis and treatment through PSA screening results in a dramatic decrease in deaths from prostate cancer; How prostate cancer is the second most frequent cause of cancer-related death among men.


Related Articles

  • PSA screening: a view from the front lines. Greiver, Michelle; Rosen, Noel // CMAJ: Canadian Medical Association Journal;3/21/2000, Vol. 162 Issue 6, p789 

    Focuses on the issue of prostate-specific antigen (PSA) screening for prostate cancer. Difficulty in advising patients about PSA screenings; How there is no evidence that screenings result in increased survival rates; Frequency of testing; Current practices.

  • New total PSA and free PSA criteria may reduce unnecessary prostate biopsies.  // Geriatrics;Jun2000, Vol. 55 Issue 6, p22 

    Discusses the results of the study conducted by researchers from Chicago, Illinois on the benefits of prostate cancer detection strategies. Benefits of using free PSA measurements; How the study was conducted; Details on the results of the study.

  • Prostate Cancer Screening; Is This a Teachable Moment? Brawley, Otis W. // JNCI: Journal of the National Cancer Institute;10/7/2009, Vol. 101 Issue 19, p1295 

    The author comments on the lessons from a research which revealed that prostate cancer screening has resulted in substantial overdiagnosis and in unnecessary treatment. The author describes how a radio commercial urging men to get screened for prostate cancer appeals to the fears and prejudices...

  • Charcot-Leyden crystals in a prostatic adenocarcinoma. Aydın, Özgür // Diagnostic Pathology;2006, Vol. 1, p26 

    A transrectal needle biopsy from a 63-year-old man was decided because of a high prostatic spesific antigen in the blood, and a hard right lobe in rectal examination. 10 examples were taken from each lobe. In 1 of 4 of the examples from the left lobe, which contained a small focus of...

  • Prognostic factors in prostate cancer. Buhmeida, A.; Pyrhönen, S.; Laato, M.; Collan, Y. // Diagnostic Pathology;2006, Vol. 1, p4 

    Prognostic factors in organ confined prostate cancer will reflect survival after surgical radical prostatectomy. Gleason score, tumour volume, surgical margins and Ki-67 index have the most significant prognosticators. Also the origins from the transitional zone, p53 status in cancer tissue,...

  • What Are Your Successful Prostate Cancer Screening Strategies? Gallo, Betty; Gatlin, Chris // ONS Connect;Sep2008, Vol. 23 Issue 9, p14 

    This section presents successful prostate cancer screening strategies. A free prostate cancer screening is being held by the Dean and Betty Gallo Prostate Cancer Center at the Cancer Institute of New Jersey in conjunction with Robert Wood Johnson University Hospital. Another screening strategy...

  • Speak Out. Jayson, Maury; Zipkin, Jeffrey W.; Jones, Gail Reede; Roddy, Timothy M. // Urology Times;Dec2009, Vol. 37 Issue 13, p27 

    The article presents several physicians' reactions regarding the American Urological Association's (AUA) recommendations that prostate-specific antigen (PSA) testing should start at age 40. Maury Jayson seconds the recommendation saying that he has seen prostate cancer cases at early ages....

  • YOUR PROSTATE IN PERIL.  // Men's Health;Nov2006, Vol. 21 Issue 9, p110 

    The article presents cities in the U.S. with the highest incident of prostate cancer. Prostate cancer could have been triggered by any number of factors may have fueled the tumor: age, ethnicity, or smoking. Prostage cancer was discovered by first analyzing prostate-cancer rates from the...

  • Overdiagnosis Since Introduction of Prostate Cancer Screening.  // JNCI: Journal of the National Cancer Institute;10/7/2009, Vol. 101 Issue 19, p1293 

    The article discusses research which revealed that the introduction of prostate-antigen screening (PSA) has led to overdiagnosis of prostate cancer. It references a study which appeared in the August 31, 2009 online issue of the "Journal of the National Cancer Institute." It has found that an...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics